Loading...
Loading chart...



The current price of CPHI is 0.6939 USD — it has increased 10.16 % in the last trading day.
China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market.
Wall Street analysts forecast CPHI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CPHI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
China Pharma Holdings Inc revenue for the last quarter amounts to 756.22K USD, decreased -31.26 % YoY.
China Pharma Holdings Inc. EPS for the last quarter amounts to -0.17 USD, decreased -73.85 % YoY.
China Pharma Holdings Inc (CPHI) has 224 emplpoyees as of February 09 2026.
Today CPHI has the market capitalization of 3.48M USD.